MedPath

Beetroot Juice Resistance Training Older Adults

Not Applicable
Completed
Conditions
Sarcopenia
Old Age; Atrophy
Registration Number
NCT05460351
Lead Sponsor
Wake Forest University
Brief Summary

The present study compared the effects of a nitrate containing beetroot juice supplement (BRJ+Nitrate) vs. a placebo (Control) on total and regional fat free mass, quadriceps muscle strength, lower body mobility, and VO2peak in healthy, older adults undergoing a 10-week long progressive resistance training program with protein supplementation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Able to provide own transportation to study testing visits and intervention
  • Able to read and write in English
  • Nondiabetic, i.e. fasting glucose < 126 mg/dl
  • Sedentary (less than 60 minutes of moderate intensity structured physical activity each week and occurs in no more than 10 minute blocks and not participating in a resistance exercise training program)
  • Willingness to provide informed consent and participate in intervention. Participants with diagnosed depression were permitted to participate provided that they have been medically stable without medication change for at least 3 months.
Exclusion Criteria
  • Smoking or use of chewing tobacco
  • Involved in another intervention research study
  • Diabetic (type 1 or 2)
  • Atrophic gastritis
  • Hypo- or hyperthyroidism
  • Gout or history of kidney stones
  • History of hypotension
  • Premenopausal (women)
  • Aversion to study-related testing procedures
  • Allergy/sensitivity/aversion to beetroot beverages or protein supplement
  • Medical conditions with contraindications for engaging in resistance training program or taking the protein supplement
  • Systemic, uncontrolled diseases (diabetes, recent (last 6 months) or current treatment of cancer, thyroid disorders, cardiovascular disease, COPD, or inflammatory bowel diseases)
  • Use of any of the following medications: phosphodiesterase type 5 inhibitors, nitroglycerin or nitrate preparations, proton pump inhibitors, or medications for hypothyroidism
  • Potential inability to complete the tasks required for the protocol as well as conditions that may interfere with interpretation of results including: inability to ambulate, severe congestive heart failure or severe cardiovascular disease, neoplasm for practical and neurophysiologic reasons
  • Individuals with contraindications for performing a graded exercise test or have medical contraindications for participating in a scheduled exercise training program
  • Individuals more than 300 pounds or less than 125 pounds due to DEXA weight limits and possibility of exceeding recommended daily nitrate dose of 7 mg/kg body weight, respectively.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Whole body fat free massCollected at 10-weeks

mass of fat free tissue

Whole body fat massCollected at 10-weeks

Mass of fat tissue

Thigh muscleCollected at 10-weeks

Volume of thigh muscle

Thigh intermuscular fatCollected at 10-weeks

Volume of fat in the thigh muscle

Thigh subcutaneous fatCollected at 10-weeks

Volume of subcutaneous fat in the thigh

Visceral fatCollected at 10-weeks

Volume of visceral fat

Muscle strengthCollected at 10-weeks

Strength of quadriceps muscle at a speed of 60 degrees per second

400 meter walkCollected at 10-weeks

Time to walk 400 meters

Stair climb timeCollected at 10-weeks

Time to ascend and descend 12 stairs

Peak oxygen consumptionCollected at baseline

Peak oxygen consumed at maximal exercise during graded exercise testing

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.